{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:28:58Z","timestamp":1761204538875,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.biocel.2023.106395","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T02:33:49Z","timestamp":1677983629000},"page":"106395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A platinum(II) complex HY1-Pt overcomes cisplatin-induced resistance and attenuates metastasis of epithelial ovarian cancer by cancer cell stemness inhibition"],"prefix":"10.1016","volume":"157","author":[{"given":"Xinyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohua","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2023.106395_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1476-4598-12-24","article-title":"Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden","volume":"12","author":"Abubaker","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biocel.2023.106395_bib2","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","article-title":"Prospective identification of tumorigenic breast cancer cells","volume":"100","author":"Al-Hajj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biocel.2023.106395_bib3","first-page":"1077","article-title":"The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?","volume":"69","author":"Bar","year":"2015","journal-title":"Post. Hig. Med. Dosw"},{"key":"10.1016\/j.biocel.2023.106395_bib4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biocel.2023.106395_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.drup.2010.12.002","article-title":"Drug transporters of platinum-based anticancer agents and their clinical significance","volume":"14","author":"Burger","year":"2011","journal-title":"Drug Resist. Update"},{"key":"10.1016\/j.biocel.2023.106395_bib6","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/IGC.0000000000001118","article-title":"Ovarian cancer prevention, screening and early detection: report from the 11th Biennial Ovarian Cancer Research Symposium","volume":"27","author":"Chien","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.biocel.2023.106395_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in ovarian cancer therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemoth. Pharm."},{"key":"10.1016\/j.biocel.2023.106395_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/15419060802198587","article-title":"Lithium chloride regulates connexin43 in skeletal myoblasts in vitro: possible involvement in wnt\/\u03b2-catenin signaling","volume":"15","author":"Du","year":"2008","journal-title":"Cell Commun. Adhes."},{"key":"10.1016\/j.biocel.2023.106395_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbapap.2007.08.017","article-title":"Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2","volume":"1784","author":"Duncan","year":"2008","journal-title":"BBA-Proteins Prote"},{"key":"10.1016\/j.biocel.2023.106395_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11864-020-00747-7","article-title":"Recurrent treatment in ovarian cancer patients: what are the best regimens and the order they should be given?","volume":"21","author":"Glajzer","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.biocel.2023.106395_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.7150\/jca.49406","article-title":"Current ovarian cancer maintenance strategies and promising new developments","volume":"12","author":"Gogineni","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.biocel.2023.106395_bib12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/cells8121500","article-title":"TGF\u03b2 family signaling pathways in pluripotent and teratocarcinoma stem cells' fate decisions: balancing between self-renewal, differentiation, and cancer","volume":"8","author":"Gordeeva","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biocel.2023.106395_bib13","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2174\/092986708785132933","article-title":"Protein kinase CK2 in human diseases","volume":"15","author":"Guerra","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.biocel.2023.106395_bib14","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1039\/D0CS00379D","article-title":"Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective","volume":"49","author":"Han","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biocel.2023.106395_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.500","article-title":"Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma","volume":"11","author":"Hao","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biocel.2023.106395_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1479-5876-9-29","article-title":"Risk factors in the development of stem cell therapy","volume":"9","author":"Herberts","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biocel.2023.106395_bib17","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1158\/1535-7163.MCT-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Landen","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biocel.2023.106395_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","article-title":"Stem cell fate in cancer growth, progression and therapy resistance","volume":"18","author":"Lytle","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biocel.2023.106395_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11010-008-9813-6","article-title":"Comparative analysis of CK2 expression and function in tumor cell lines displaying sensitivity vs. resistance to chemical induced apoptosis","volume":"316","author":"Maira","year":"2008","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.biocel.2023.106395_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.canlet.2015.11.013","article-title":"Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt\/\u03b2-catenin signaling","volume":"370","author":"Martins-Neves","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biocel.2023.106395_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00404-013-3114-3","article-title":"The heterogeneity of ovarian cancer","volume":"289","author":"Meinhold-Heerlein","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.biocel.2023.106395_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.03.005","article-title":"Role of OCT4 in cancer stem-like cells and chemotherapy resistance","volume":"1866","author":"Mohiuddin","year":"2020","journal-title":"BBA-Mol. Basis. Dis."},{"key":"10.1016\/j.biocel.2023.106395_bib23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int. J. Women'S. Health"},{"key":"10.1016\/j.biocel.2023.106395_bib24","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1038\/onc.2014.299","article-title":"Casein kinase 2\u03b1 regulates glioblastoma brain tumor-initiating cell growth through the \u03b2-catenin pathway","volume":"34","author":"Nitta","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.biocel.2023.106395_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","article-title":"Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content","volume":"140","author":"Pece","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2023.106395_bib26","doi-asserted-by":"crossref","first-page":"i51","DOI":"10.1093\/annonc\/mdx441","article-title":"Treatment of recurrent ovarian cancer","volume":"28","author":"Pignata","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biocel.2023.106395_bib27","doi-asserted-by":"crossref","first-page":"i63","DOI":"10.1093\/annonc\/mdw079","article-title":"Recurrent ovarian cancer","volume":"27","author":"Pujade-Lauraine","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biocel.2023.106395_bib28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1021\/cb3007133","article-title":"First structure of protein kinase CK2 catalytic subunit with an effective CK2\u03b2-competitive ligand","volume":"8","author":"Raaf","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.biocel.2023.106395_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13287-022-02856-6","article-title":"Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells","volume":"13","author":"Rezayatmand","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biocel.2023.106395_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104517","article-title":"Plumbagin inhibits cancer stem-like cells, angiogenesis and suppresses cell proliferation and invasion by targeting Wnt\/\u03b2-catenin pathway in endocrine resistant breast cancer","volume":"150","author":"Sakunrangsit","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biocel.2023.106395_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-016-0502-x","article-title":"Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications","volume":"15","author":"Serrano-Gomez","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biocel.2023.106395_bib32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/cancers11060813","article-title":"Hexokinase 2 regulates ovarian cancer cell migration, invasion and stemness via FAK\/ERK1\/2\/MMP9\/NANOG\/SOX9 signaling cascades","volume":"11","author":"Siu","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.biocel.2023.106395_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian cancer: An integrated review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.biocel.2023.106395_bib34","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA-A Cancer J. Clin."},{"key":"10.1016\/j.biocel.2023.106395_bib35","first-page":"284","article-title":"Ovarian cancer statistics","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biocel.2023.106395_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/leu.2016.209","article-title":"Protein kinase CK2 regulates AKT, NF-kappa B and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia","volume":"31","author":"Tubi","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.biocel.2023.106395_bib37","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1021\/acs.jmedchem.1c00131","article-title":"Discovery of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine derivatives as highly selective CK2 inhibitors with potent cancer cell stemness inhibition","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biocel.2023.106395_bib38","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1021\/acs.jmedchem.1c00079","article-title":"A novel CK2 specific Pt(II) compound reverses cisplatin-induced resistance by inhibiting cancer cell stemness and suppressing DNA damage repair in NSCLC treatments","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biocel.2023.106395_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1369\/0022155411428469","article-title":"Breast and ovarian cancers: a survey and possible roles for the cell surface heparan sulfate proteoglycans","volume":"60","author":"Yoneda","year":"2012","journal-title":"J. Histochem. Cytochem"},{"key":"10.1016\/j.biocel.2023.106395_bib40","first-page":"15216","article-title":"Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand","volume":"14","author":"Zhao","year":"2020","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.biocel.2023.106395_bib41","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/cancers11070934","article-title":"Ovarian cancer stem cells: role in metastasis and opportunity for therapeutic targeting","volume":"11","author":"Zong","year":"2019","journal-title":"Cancers"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272523000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272523000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:24:47Z","timestamp":1761204287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272523000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":41,"alternative-id":["S1357272523000341"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2023.106395","relation":{},"ISSN":["1357-2725"],"issn-type":[{"type":"print","value":"1357-2725"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A platinum(II) complex HY1-Pt overcomes cisplatin-induced resistance and attenuates metastasis of epithelial ovarian cancer by cancer cell stemness inhibition","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2023.106395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106395"}}